Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrol Gamble

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Trials|January 30, 2024
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stageAlice-Maria Toader, Marion K Campbell, Jennifer K Quint, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
The Lancet. Respiratory Medicine|March 24, 2026
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trialMalcolm G Semple, Chloe Donohue, Laura Price, et al.
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
The New England Journal of Medicine|November 19, 2025
A Multicomponent Intervention to Improve Maternal Infection OutcomesDavid Lissauer, Luis Gadama, Catriona Waitt, et al.
The New England Journal of Medicine|August 30, 2023
Timing of Primary Surgery for Cleft PalateCarrol Gamble, Christina Persson, Elisabeth Willadsen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 11, 2025
Frailty increases the risk of hospitalization for atrial fibrillation in older adults: a population-based cohort studyCaterina Trevisan, Chiara Ceolin, Davide Liborio Vetrano, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Lancet (London, England)|March 27, 2007
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialAnthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, et al.
Neuro-Oncology|March 14, 2022
Opportunities and challenges for the development of "core outcome sets" in neuro-oncologyChristopher P Millward, Terri S Armstrong, Heather Barrington, et al.
Trials|January 30, 2024
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stageAlice-Maria Toader, Marion K Campbell, Jennifer K Quint, et al.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
The Lancet. Respiratory Medicine|March 24, 2026
Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trialMalcolm G Semple, Chloe Donohue, Laura Price, et al.
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
The New England Journal of Medicine|November 19, 2025
A Multicomponent Intervention to Improve Maternal Infection OutcomesDavid Lissauer, Luis Gadama, Catriona Waitt, et al.
The New England Journal of Medicine|August 30, 2023
Timing of Primary Surgery for Cleft PalateCarrol Gamble, Christina Persson, Elisabeth Willadsen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 11, 2025
Frailty increases the risk of hospitalization for atrial fibrillation in older adults: a population-based cohort studyCaterina Trevisan, Chiara Ceolin, Davide Liborio Vetrano, et al.
Pageof 15